The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Factors Associated With Failure to Publish Large Randomized Trials Presented at an Oncology Meeting
Abstract
CONTEXT: Large clinical trials are the criterion standard for making treatment decisions, and nonpublication of the results of such trials can lead to bias in the literature and contribute to inappropriate medical decisions. OBJECTIVES: To determine the rate of full publication of large randomized trials presented at annual meetings of the American Society of Clinical Oncology (ASCO), quantify bias against publishing nonsignificant results, and identify factors associated with time to publication. DESIGN: Survey of 510 abstracts from large (sample size, > or =200), phase 3, randomized controlled trials presented at ASCO meetings between 1989 and 1998. Trial results were classified as significant (P< or =.05 for the primary outcome measure) or nonsignificant (P>.05 or not reported), and the type of presentation and sponsorship were identified. Subsequent full publication was identified using a search of MEDLINE and EMBASE, completed November 1, 2001; the search was updated in November 2002, using the Cochrane Register of Controlled Trials. Authors were contacted if the searches did not find evidence of publication. MAIN OUTCOME MEASURES: Publication rate at 5 years; time from presentation to full publication. RESULTS: Of 510 randomized trials, 26% were not published in full within 5 years after presentation at the meeting. Eighty-one percent of the studies with significant results had been published by this time compared with 68% of the studies with nonsignificant results (P<.001). Studies with oral or plenary presentation were published sooner than those not presented (P =.002), and studies with pharmaceutical sponsorship were published sooner than studies with cooperative group sponsorship or studies for which sponsorship was not specified (P =.02). These factors remained significant in a multivariable model. The most frequent reason cited by authors for not publishing was lack of time, funds, or other resources. CONCLUSIONS: A substantial number of large phase 3 trials presented at an international oncology meeting remain unpublished 5 years after presentation. Bias against publishing nonsignificant results is a problem even for large randomized trials. Nonpublication breaks the contract that investigators make with trial participants, funding agencies, and ethics boards.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109
Sterling, T. D. (1959) · Journal of the American Statistical Association · doi:10.1080/01621459.1959.10501497 · Cited by 964
Dickersin, K. (1992) · JAMA · doi:10.1001/jama.1992.03480030052036 · Cited by 854
Publication bias: evidence of delayed publication in a cohort study of clinical research projects
Stern, J. M., & Simes, R. J. (1997) · BMJ · doi:10.1136/bmj.315.7109.640 · Cited by 818
Publication bias: the case for an international registry of clinical trials.
Simes, R. J. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.10.1529 · Cited by 747
Publication bias and clinical trials
Dickersin, K., Chan, S., Chalmersx, T. C., Sacks, H. S., & Smith, H. (1987) · Controlled Clinical Trials · doi:10.1016/0197-2456(87)90155-3 · Cited by 715 · cited 1×
“Research into reasons for nonpublication suggests that often the authors are influenced by results of the study and lose interest in negative studies.(4,6) Few studies have addressed publication bias in relation to randomized trials.”
ResultIoannidis, J. P. A. (1998) · JAMA · doi:10.1001/jama.279.4.281 · Cited by 632
Underreporting Research Is Scientific Misconduct
Chalmers, L. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440100121018 · Cited by 551
Egger, M., & Smith, G. D. (1995) · BMJ · doi:10.1136/bmj.310.6982.752 · Cited by 508
Publication Bias: The Problem That Won't Go Away
DICKERSIN, K., & MIN, Y. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb26343.x · Cited by 427
Source of funding and outcome of clinical trials
Davidson, R. A. (1986) · Journal of General Internal Medicine · doi:10.1007/bf02602327 · Cited by 397
How important is publication bias? A synthesis of available data.
Dickersin, K. (1997) · PubMed · Cited by 311
Full Publication of Results Initially Presented in Abstracts: A Meta-analysis
Scherer, R. W. (1994) · JAMA · doi:10.1001/jama.1994.03520020084025 · Cited by 296
Rochon, P. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.2.157 · Cited by 274
Unpublished Research From a Medical Specialty Meeting: Why Investigators Fail to Publish
Weber, E. J., Callaham, M. L., Wears, R. L., Barton, C., & Young, G. (1998) · JAMA · doi:10.1001/jama.280.3.257 · Cited by 262
A Cohort Study of Summary Reports of Controlled Trials
Chalmers, L. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440100117017 · Cited by 202
Savulescu, J., Chalmers, I., & Blunt, J. (1996) · BMJ · doi:10.1136/bmj.313.7069.1390 · Cited by 188
BIAS AGAINST THE NULL HYPOTHESIS: THE REPRODUCTIVE HAZARDS OF COCAINE
Koren, G., Shear, H., Graham, K., & Einarson, T. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92044-8 · Cited by 173
Fate of Cardiology Research Originally Published in Abstract Form
Goldman, L., & Loscalzo, A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007313030504 · Cited by 160
Bellefeuille, C., Morrison, C. A., & Tannock, I. F. (1992) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058147 · Cited by 142
Timmer, A., Hilsden, R. J., Cole, J., Hailey, D. M., & Sutherland, L. R. (2002) · BMC Medical Research Methodology · doi:10.1186/1471-2288-2-7 · Cited by 103
Klassen, T. P., Wiebe, N., Russell, K. F., Stevens, K. R., Hartling, L., Craig, W. R., & Moher, D. (2002) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.156.5.474 · Cited by 95
Manheimer, E. W., & Anderson, D. (2002) · BMJ · doi:10.1136/bmj.325.7363.528 · Cited by 57
Horton, R. C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62564-0 · Cited by 43
Time to publication as full reports of abstracts of randomized controlled trials in cystic fibrosis
Cheng, K., Gamble, C. L., Ashby, D., O'Hea, U., & Smyth, R. L. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199808)26:2<101::aid-ppul5>3.0.co;2-p · Cited by 37
Cited by
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Italian Journal of Public Health · doi:10.2427/5768 · Cited by 3,374
Metadata
- Authors
- Krzyzanowska, M. K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-07-23
- Volume
- 290
- Issue
- 4
- Pages
- 495
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2065347109
- Cited by
- 314
- References
- 25
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.